Forum Financial Management, LP Horizon Therapeutics Public LTD CO Transaction History

Forum Financial Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	SELL	$98.98 - $115.74 $115,212 - $134,721	-1,164 Reduced 19.05%	4,945 $572,000
Q1 2023 Apr 19, 2023	BUY	$107.32 - $113.5 $24,468 - $25,878	228 Added 3.88%	6,109 $666,000
Q4 2022 Jan 24, 2023	SELL	$62.39 - $113.8 $90,153 - $164,441	-1,445 Reduced 19.72%	5,881 $0
Q3 2022 Nov 07, 2022	BUY	$58.92 - $84.67 $127,149 - $182,717	2,158 Added 41.76%	7,326 $453,000
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $5,558 - $8,145	70 Added 1.37%	5,168 $412,000

Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $90,308 - $114,751	-1,045 Reduced 17.01%	5,098 $536,000
Q4 2021 Feb 18, 2022	BUY	$98.56 - $119.91 $605,454 - $736,607	6,143 New	6,143 $662,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Forum Financial Management, LP, based on Form 13F filings with the SEC.

Stay updated on Forum Financial Management, LP with notifications on news.